WASHINGTON (AP) — An experimental COVID-19 vaccine from Novavax appears to offer strong protection in late-stage UK, South Africa studies.
Copyright © 2021 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
